Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

(MDRX)
  Report
Delayed Nasdaq  -  04:00 2022-12-02 pm EST
19.06 USD   +0.85%
11/30Sphere's TrustCommerce® Healthcare Payments Platform Now Integrated with Veradigm® Practice Management
PR
11/22Veradigm Digital Health Media Becomes the First EHR Marketing Solution to Join the Point of Care Marketing Association
BU
11/18JPMorgan Adjusts Price Target on Allscripts Healthcare Solutions to $20 From $19, Maintains Underweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Pulse8 Receives NCQA Measure Certification™ for HEDIS® MY2022 for Qualit8™, a Veradigm Network Solution

07/19/2022 | 08:16am EST

Pulse8 is thrilled to announce that Qualit8, a Veradigm Network Solution, has achieved MY2022 Measure Certification from the National Committee for Quality Assurance (NCQA) for the third consecutive year. Veradigm® is a leading provider of healthcare data, analytics and technology solutions and a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX). By earning NCQA Measure Certification, the industry’s most rigorous assessment, Qualit8 demonstrates a commitment to delivering value and administrative efficiency to health plan customers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220719005124/en/

Combining our Qualit8 Quality Improvement Analytics with an NCQA-Certified HEDIS® Measurement Certification Program allows health plans to gain line of sight into HEDIS measure performance and optimize gap closure workflows towards maximum efficiency.

Pulse8’s NCQA-Certified HEDIS MY2022 Measure program includes:

  • HEDIS Health Plan Measures Certification
  • Allowable Adjustment Measures Certification
  • ECDS Measures Certification
  • Hybrid Sampling Certification

“This certification is a prime example of how Veradigm continues to deliver industry-leading, transparent analytics to our health plan customers,” says President and Chief Commercial Officer Tom Langan. “As a Veradigm Network solution, Qualit8’s NCQA-Certified HEDIS® Measurement and Reporting Software provides health plans with a higher level of value by helping reduce healthcare spending, waste and improving administrative efficiency.”

You can learn more about Qualit8 Certification and Veradigm’s full suite of products at https://veradigm.com/quality-analytics/.

NCQA is a private, non-profit organization dedicated to improving health care quality. NCQA Measure Certification Program™ is a trademark of the National Committee for Quality Assurance (NCQA). HEDIS® is a registered trademark of the of the National Committee for Quality Assurance (NCQA).

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. Some healthcare technology companies deliver clinical data for biopharma and health plans, some help turn that data into insights, others serve healthcare providers directly by providing point-of-care clinical software and patient outreach platforms. Veradigm does it all. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.

For more information on Veradigm, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2022 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.


© Business Wire 2022
All news about ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
11/30Sphere's TrustCommerce® Healthcare Payments Platform Now Integrated with Veradigm® Prac..
PR
11/22Veradigm Digital Health Media Becomes the First EHR Marketing Solution to Join the Poin..
BU
11/18JPMorgan Adjusts Price Target on Allscripts Healthcare Solutions to $20 From $19, Maint..
MT
11/14Insider Sell: Allscripts Healthcare Solutions
MT
11/10Allscripts - Veradigm EHR Achieves 2015 ONC Health IT Update Certification
AQ
11/09Goldman Sachs Upgrades Allscripts Healthcare Solutions to Buy From Neutral, Adjusts Pri..
MT
11/09Veradigm EHR Achieves 2015 ONC Health IT Update Certification
BU
11/07ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. Management's Discussion and Analysis of Financia..
AQ
11/07Tranche Update on Allscripts Healthcare Solutions, Inc.'s Equity Buyback Plan announced..
CI
11/07Deutsche Bank Adjusts Allscripts Healthcare Solutions Price Target to $21 From $20, Mai..
MT
More news
Analyst Recommendations on ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
More recommendations
Financials (USD)
Sales 2022 615 M - -
Net income 2022 1,69 M - -
Net cash 2022 300 M - -
P/E ratio 2022 -318x
Yield 2022 -
Capitalization 2 082 M 2 082 M -
EV / Sales 2022 2,90x
EV / Sales 2023 2,74x
Nbr of Employees 8 000
Free-Float 38,1%
Chart ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Duration : Period :
Allscripts Healthcare Solutions, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 19,06 $
Average target price 22,00 $
Spread / Average Target 15,4%
EPS Revisions
Managers and Directors
Richard J. Poulton Chief Executive Officer & Director
Thomas Langan President
Leah Jones Vice President-Finance & Sales Support
Joseph R. Rostock Chief Technology Officer & SVP-Product Engineering
Tejal Vakharia Chief Compliance Counsel & Senior VP
Sector and Competitors
1st jan.Capi. (M$)
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.2.44%2 082
VEEVA SYSTEMS INC.-31.54%27 159
PRO MEDICUS LIMITED-2.35%4 319
SECTRA AB (PUBL)-12.29%3 258
EVOLENT HEALTH, INC.3.29%2 848
OMNICELL, INC.-71.82%2 270